Benefit of SGLT2i in HFpEF by reduction of clinically meaningful CV events

3' education - Sep. 15, 2021 - Prof. Stefan Anker, MD, PhD - Berlin, Germany

Educational information

This video was recorded during the digital ESC Congress 2021.

Prof. Stefan D. Anker is Head of Field “Tissue Homeostasis and Cachexia" at Charité University, Berlin, Germany.

The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of EPCCS.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.